Form D — Oric Pharmaceuticals, Inc.

0001796280-25-000001 · filed Jun 6, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $125,000,000
Reported amount sold: $125,000,000
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Oric Pharmaceuticals, Inc.
CIK: 1796280
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 240 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 388-5600

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Jacob M. Chacko · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Pratik Multani · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Dominic Piscitelli · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Richard Heyman · Director

South San Francisco, CA Find on LinkedIn ↗
Mardi C. Dier · Director

South San Francisco, CA Find on LinkedIn ↗
Steve L. Hoerter · Director

South San Francisco, CA Find on LinkedIn ↗
Lori Kunkel · Director

South San Francisco, CA Find on LinkedIn ↗
Angie You · Director

South San Francisco, CA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗